2023;79:104055 Mahani M, Taheri M, Divsar F, Khakbaz F, Nomani A, Ju H
veterans with type 2 diabetes taking the drugs showed that halting or interrupting treatment was linked to a significant increase in the risk of major cardiovascular events
Obesity and suicide risk in adultsa systematic review
Sustained body recomposition
The Journal of Biochemistry, 175 (5), 473-480
extended for analogs) GLP-3: Not well characterized Side Effects GLP-1: Nausea (common initially) Vomiting Diarrhea or constipation Reduced appetite Potential pancreatitis (rare) GLP-2: Generally well-tolerated Injection site reactions Abdominal pain or discomfort Nausea (less common than GLP-1) Fluid retention GLP-3: Unknown (no clinical use) Availability GLP-1: Widely available through prescription medications (semaglutide, liraglutide, etc.) and research peptides GLP-2: Available as teduglutide (Gattex/Revestive) by prescription